[Funding Alert] Singapore-Based Gero Raises $2.2 Mn In Series A Round

The round was led by Bulba Ventures, along with existing investors and serial entrepreneurs in the fields of pharmaceuticals, IT and AI

learn more about Debarghya Sil

By Debarghya Sil • Aug 5, 2020

Pixabay
Representational

You're reading Entrepreneur Asia Pacific, an international franchise of Entrepreneur Media.

Gero, a Singapore-based artificial intelligence (AI) platform that focuses on developing drugs to prevent ageing and other disorders, on Tuesday announced it has received funding worth $2.2 million in a Series A round led by Bulba Ventures, along with existing investors and serial entrepreneurs in the fields of pharmaceuticals, IT and AI.

With this funding, the company has raised a total capital worth $7.5 million.

The latest development has led Yury Melnichek, co-founder of Bulba Ventures, to join Gero's board of directors.

The company said it will utilize the fresh funds to develop its AI platform for analysing clinical and genetic data to find treatments for "complicated" disease" which are age-related chronic illnesses, mental illnesses and others.

Commenting on the funding, Peter Fedichev, founder of Gero, said, "We are happy with the recognition and support from these strategic investors who themselves are acknowledged leaders in the fields of AI and biotechnology. This will help us attain the necessary knowledge at the junction of biological sciences and AI/ML technologies that is necessary for the radial acceleration of drug discovery."

"We hope that the technology will soon lead to a meaningful healthspan extension and quality of life improvement," he added.

The company after analyzing large datasets of medical and genetic information from scores people have found a protein in the blood which if removed or blocked should lead to rejuvenation.

The company said experiments at the National University of Singapore involving aged animals demonstrated mortality delay (life-extension) and functional improvements after a single experimental treatment.

In the future, this new drug could enable patients to recover after a stroke and could help cancer patients in their fight against accelerated ageing resulting from chemotherapy.

The biotech firm's platform is also currently being used to find therapies for COVID-19 treatment.

Debarghya Sil

Entrepreneur Staff

Former Correspondent

Related Topics

Business News

Frontier Airlines Just Announced Its All-You-Can-Fly Summer Pass for $399. What's the Catch?

As travel begins to pick up, the airline hopes unlimited travel will jumpstart its business.

Thought Leaders

5 Small Daily Habits Self-Made Millionaires Use to Grow Their Wealth

We've all seen what self-made millionaires look like on TV, but it's a lot more subtle than that. Brian Tracy researched what small daily habits these successful entrepreneurs adopted on their journey from rags to riches.

Career

60 Second Business Tips: 3 Ways to Boost Confidence

Business development consultant Terry Rice on silencing self-doubt.

Technology

Entrance Of This High-Tech Drone Company Is Yet Another Marker of India's Dynamic Growth Economy

Draganfly has entered into a partnership with India's Remote Sensing Instruments to work together to create even better software

Leadership

Two Stanford Professors Explain How to Produce Hundreds of World-Changing Ideas In 1 Hour

Cramming everyone into a conference room to "spitball" is a disaster. But with some structure and a system, literally thousands of ideas are within reach.